Envista Holdings (NVST) Cash from Financing Activities (2018 - 2026)

Envista Holdings' (NVST) quarterly Cash from Financing Activities came in at -$45.6 million in Q2 2026, down 159.09% year-on-year from $77.2 million in Q2 2025, and down 80.95% quarter-over-quarter from -$25.2 million in Q4 2025.

Envista Holdings (NVST) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Envista Holdings' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$45.6 million for Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 159.09% year-over-year to -$45.6 million in Q2 2026; TTM through Apr 2026 was -$198.9 million, a 67.57% decrease from a year earlier, with the FY2025 full-year figure at -$170.9 million, down 64.8% from the prior year.
  • Cash from Financing Activities slipped to -$45.6 million in Q2 2026 per NVST's latest filing, from -$25.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $114.5 million in Q3 2023 and bottomed at -$100.5 million in Q3 2024.
  • The 5-year median for Cash from Financing Activities is -$1.5 million (2023), against an average of -$11.1 million.
  • Across the five-year window, Cash from Financing Activities soared 1813.95% in 2022 and sank 28900.0% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$68.3 million in 2022, then surged by 104.83% to $3.3 million in 2023, then plunged by 127.27% to -$900000.0 in 2024, then sank by 2700.0% to -$25.2 million in 2025, then plunged by 80.95% to -$45.6 million in 2026.
  • Per Business Quant, the three latest NVST Cash from Financing Activities figures stand at -$45.6 million (Q2 2026), -$25.2 million (Q4 2025), and -$41.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -133.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -287.90 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -414.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -13.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -255.24 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -164.80 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -75.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -50.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -48.13 Mn
10 Envista Holdings 4.29 Bn 3.20 Bn 390.10 Mn -45.60 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -45.60 Mn
Apr 3, 2026 -45.60 Mn
Dec 31, 2025 -25.20 Mn
Dec 31, 2025 -25.20 Mn
Sep 26, 2025 -41.70 Mn
Sep 26, 2025 -41.70 Mn
Jun 27, 2025 -86.40 Mn
Jun 27, 2025 -86.40 Mn
Mar 28, 2025 -17.60 Mn
Mar 28, 2025 -17.60 Mn
Dec 31, 2024 -900,000.00
Dec 31, 2024 -900,000.00
Sep 27, 2024 -100.50 Mn
Sep 27, 2024 -100.50 Mn
Jun 28, 2024 300,000.00
Jun 28, 2024 300,000.00
Mar 29, 2024 -2.60 Mn
Mar 29, 2024 -2.60 Mn
Dec 31, 2023 3.30 Mn
Dec 31, 2023 3.30 Mn